<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20013" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Coronary Artery Perforation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nagalli</surname>
            <given-names>Shivaraj</given-names>
          </name>
          <aff>Yuma Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hajouli</surname>
            <given-names>Said</given-names>
          </name>
          <aff>Logan Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shivaraj Nagalli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Said Hajouli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20013.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Coronary artery perforation is a rare complication associated with a percutaneous coronary intervention. This activity highlights the risk factors, deadly consequences, and various treatment approaches available to the interprofessional team to deal with this life-threating complication.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology and epidemiology of coronary artery perforation.</p></list-item><list-item><p>Review the appropriate history, physical, and evaluation of coronary artery perforation.</p></list-item><list-item><p>Outline the treatment and management options available for coronary artery perforation.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication to advance coronary artery perforation and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20013&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20013">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20013.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Coronary artery perforation (CAP) is, fortunately, a rare but serious life-threatening complication of a percutaneous coronary intervention (PCI), which in severe cases lead to cardiac tamponade, cardiogenic shock, myocardial infarction, and even death, if there is no intervention.</p>
      </sec>
      <sec id="article-20013.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Risk factors</bold>
</p>
        <p>CAP is reported to be directly proportional to the complexity of coronary artery disease.<xref ref-type="bibr" rid="article-20013.r1">[1]</xref> Risk factors can be categorized as follows:&#x000a0;&#x000a0;</p>
        <p>
<italic toggle="yes">
<bold>A. Non-modifiable risk factors</bold>
</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Old age<xref ref-type="bibr" rid="article-20013.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Female gender<xref ref-type="bibr" rid="article-20013.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>History of previous coronary artery bypass graft (CABG)<xref ref-type="bibr" rid="article-20013.r3">[3]</xref><xref ref-type="bibr" rid="article-20013.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Use of clopidogrel<xref ref-type="bibr" rid="article-20013.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">
<bold>B. Modifiable risk factors</bold>
</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Presence of hypertension <xref ref-type="bibr" rid="article-20013.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Presence of peripheral artery disease</p>
          </list-item>
          <list-item>
            <p>Presence of congestive heart failure<xref ref-type="bibr" rid="article-20013.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Lower body mass index</p>
          </list-item>
          <list-item>
            <p>Lower creatinine clearance<xref ref-type="bibr" rid="article-20013.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>&#x000a0;<italic toggle="yes"><bold>C. Risk factors associated with coronary anatomy and catheterization</bold></italic></p>
        <list list-type="bullet">
          <list-item>
            <p>Complex coronary lesions (ACC/AHA Type B2, C)<xref ref-type="bibr" rid="article-20013.r7">[7]</xref><xref ref-type="bibr" rid="article-20013.r8">[8]</xref><xref ref-type="bibr" rid="article-20013.r9">[9]</xref><xref ref-type="bibr" rid="article-20013.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Chronic total occlusions, heavily calcified lesions, angulated, tortuous lesions, narrow coronary arteries<xref ref-type="bibr" rid="article-20013.r7">[7]</xref><xref ref-type="bibr" rid="article-20013.r9">[9]</xref><xref ref-type="bibr" rid="article-20013.r10">[10]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Aggressive use of oversized balloons and stents<xref ref-type="bibr" rid="article-20013.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Use of atheroablative devices and hydrophilic guidewires<xref ref-type="bibr" rid="article-20013.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20013.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Incidence is reported to be low and can vary between 0.1% and 3% based on the several case series with the highest risk of CAP occurring while dealing with chronic total occlusions.<xref ref-type="bibr" rid="article-20013.r2">[2]</xref><xref ref-type="bibr" rid="article-20013.r5">[5]</xref><xref ref-type="bibr" rid="article-20013.r7">[7]</xref><xref ref-type="bibr" rid="article-20013.r11">[11]</xref>&#x000a0;Mortality rates can be as high as 21.2%, depending on the severity of CAP.<xref ref-type="bibr" rid="article-20013.r7">[7]</xref>&#x000a0;CAP is more common among the elderly and females, as noted above.</p>
      </sec>
      <sec id="article-20013.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>CAP leads to pericardial effusion, tamponade, cardiogenic shock, myocardial infarction, and even death. Hence the necessity of understanding the type and severity of perforation. Ellis classification is the most common system used in classifying CAPs. Based on the coronary angiographic findings, these are divided into three types, as follows<xref ref-type="bibr" rid="article-20013.r12">[12]</xref>:&#x000a0;</p>
        <p><bold>Type I:</bold> Presence of extraluminal crater without extravasation</p>
        <p><bold>Type II:</bold> Presence of pericardial or myocardial blush without contrast jet extravasation</p>
        <p><bold>Type III:</bold> Presence of contrast jet extravasation through frank perforation (&#x02265;1 mm)</p>
        <p><bold>Type III (CS):</bold> Presence of contrast jet extravasation into the cavities like a cardiac chamber or coronary sinus</p>
      </sec>
      <sec id="article-20013.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most of the CAPs are recognized at the time of perforation during coronary angiography. However, subtle CAPs can go unrecognized. Acute onset of shortness of breath, hypotension, unexplained new-onset tachycardia, recurrent or persistent chest pain can develop in these later situations. CAP needs to be in the differential in these situations. As little as an accumulation of 100 ml of blood in pericardial space in the acute setting is sufficient to cause hemodynamic instability.<xref ref-type="bibr" rid="article-20013.r13">[13]</xref> New-onset pericardial effusion on chest X-ray and a beside echocardiography post coronary intervention are diagnostic. Cardiac tamponade is associated with type B2 and C, type III CAPs,&#x000a0;and with the use of atheroablative devices.<xref ref-type="bibr" rid="article-20013.r2">[2]</xref><xref ref-type="bibr" rid="article-20013.r7">[7]</xref><xref ref-type="bibr" rid="article-20013.r12">[12]</xref><xref ref-type="bibr" rid="article-20013.r4">[4]</xref><xref ref-type="bibr" rid="article-20013.r14">[14]</xref><xref ref-type="bibr" rid="article-20013.r15">[15]</xref><xref ref-type="bibr" rid="article-20013.r14">[14]</xref><xref ref-type="bibr" rid="article-20013.r16">[16]</xref> Delayed pericardial effusions can also be seen up to 9 days from the day of cardiac catheterization and can be challenging to diagnose.&#x000a0;Pseudoaneurysms of coronaries can also develop at the site of CAPs. These have been reported to be as early as within 10 min from the time of PCI, with most cases between 2 weeks and 3 months.<xref ref-type="bibr" rid="article-20013.r17">[17]</xref></p>
      </sec>
      <sec id="article-20013.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>CAPs diagnosis is by coronary angiography. The importance of early recognition and intervention cannot be overemphasized.&#x000a0;Serial echocardiography can be of help in diagnosing late development of pericardial effusions and tamponade, especially in patients managed with a conservative approach.</p>
      </sec>
      <sec id="article-20013.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The goals of the management of CAPs are immediate hemodynamic stabilization and sealing the site of perforation to prevent dire consequences. Although there are no universally accepted treatment protocols, the following are the suggested treatment approaches:</p>
        <p>
<bold>I. General approaches:&#x000a0;</bold>
</p>
        <p>Adequate blood pressure support is needed. Intraaortic balloon pump may be necessary. Antiplatelets and anticoagulants need to be discontinued. Protamine infusion may be required to counteract the effect of anticoagulation. Platelet transfusion can be of some benefit, especially in those patients who have received GP-IIb/IIIa receptor antagonists. Urgent pericardiocentesis in the setting of cardiac tamponade can be life-saving. Low pressure prolonged proximal balloon inflation should take place immediately after the CAP has occurred during coronary angiography. This process is necessary to assess the severity of CAP, prevent further blood leakage, and to gain time until determining a definitive plan.&#x000a0;</p>
        <p>
<bold>II. Specific approaches:&#x000a0;</bold>
</p>
        <p>CAPs with Ellis type I and II are conservatively managed, with most cases underwent management with prolonged balloon inflation alone. <xref ref-type="bibr" rid="article-20013.r1">[1]</xref> Serial Echocardiography after diagnosis can be helpful for timely diagnosis and management of pericardial effusions/ tamponade.&#x000a0;</p>
        <p>A more severe type of CAPs (type III) treatment is via the following approaches.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Covered Stents (CS):</bold> The stents, initially used to treat in-stent stenosis, are used to seal the site of perforation and prevent leakage of blood. These are commonly used for proximal larger perforations. Polytetrafluoroethylene (PTFE) covered stents are widely used. Several other types of CS are also available. A study comparing the outcomes with the use of PTFE vs. polyurethane CS showed no significant differences in procedural success or major adverse cardiovascular events but showed a decrease in the rates of pericardial effusions and cardiac arrest in patients when using PTFE covered stents.<xref ref-type="bibr" rid="article-20013.r18">[18]</xref> The disadvantages of using these stents include thrombogenicity and occlusion of coronary branches.<xref ref-type="bibr" rid="article-20013.r18">[18]</xref> However, these demonstrate a decrease in the incidence of pericardiocentesis and the need for emergency surgeries. There are several other CS made from autologous veins and equine pericardium, but their use requires expertise and time.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Coils:</bold> These are made of metallic agents like stainless steel or platinum with wired structures made of PTFE or synthetic wool, which have thrombogenic properties and delivery is through guide wires or microcatheter.<xref ref-type="bibr" rid="article-20013.r18">[18]</xref> These are commonly used for distal coronary artery perforations. The size of these coils needs to be larger than the size of the vessel involved.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Microspheres:</bold> These are spherical, hydrophilic, and non-absorbable particles that are delivered through microcatheters to and cause precise sealing of perforations.<xref ref-type="bibr" rid="article-20013.r18">[18]</xref> Its typical use is for distal sites of CAP similar to coils.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Others:</bold> Autologous blood clots suspended in contrast and saline can cause adequate sealing of CAP.<xref ref-type="bibr" rid="article-20013.r18">[18]</xref> Thrombin injection can also help in sealing CAP by assisting in the formation of fibrin clots. Autologous subcutaneous fat also works to seal the perforation. Using blood clots and fat particles have the advantage of biocompatibility and are widely available.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Surgery:</bold> A cardiac surgeon needs to have involvement if cardiac tamponade is not feasible or if a pericardiocentesis does not yield appropriate results.<xref ref-type="bibr" rid="article-20013.r19">[19]</xref> Emergency repair of CAPs or CABG in these settings also carries significant mortality risk.<xref ref-type="bibr" rid="article-20013.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20013.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The diagnosis of CAP is usually instant during the coronary angiography. However, hemodynamic instability and persistent symptoms can be present in acute coronary syndrome, coronary artery dissection, aortic dissection, chordae tendinae rupture, and myocardial rupture.</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute coronary syndrome</p>
          </list-item>
          <list-item>
            <p>Coronary artery dissection</p>
          </list-item>
          <list-item>
            <p>Aortic dissection</p>
          </list-item>
          <list-item>
            <p>Chordae tendinae rupture</p>
          </list-item>
          <list-item>
            <p>Myocardial rupture</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20013.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of CAP depends on the severity. Ellis types I and II are conservatively managed, and most of the patients end up in spontaneous resolution or develop pseudoaneurysms. However, smaller portions develop delayed pericardial effusions and hence the necessity of serial echocardiography for the first 48 hours after diagnosing CAP. Ellis type III has a high mortality rate if ensuing cardiac tamponade is not taken care of by the above measures.&#x000a0;</p>
      </sec>
      <sec id="article-20013.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac tamponade</p>
          </list-item>
          <list-item>
            <p>Cardiogenic shock</p>
          </list-item>
          <list-item>
            <p>Myocardial Infarction</p>
          </list-item>
          <list-item>
            <p>Cardiac arrest</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20013.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although a rare risk, a proper explanation to the patients of this possibility during PCI before subjecting them to cardiac catheterization is necessary so that patients can give appropriately informed consent.&#x000a0;</p>
      </sec>
      <sec id="article-20013.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team approach is necessary to deal with this dire complication. The healthcare personnel, including registered nurses, physicians, and cardiologists, should be appropriately trained to suspect any early symptoms and signs of CAP. This applies to the cardiology nursing staff and medical assistants who will monitor the patient following PCI, who can then alert the cardiac surgeon or other clinical staff immediately.&#x000a0;This is why a cardiothoracic surgeon and anesthesiologist should be informed and readily available if the usual treatment strategies fail to contain the coronary artery perforation. WIth interprofessional effort, the rare complication can be addressed promptly and potentially save lives. [Level 5]</p>
      </sec>
      <sec id="article-20013.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20013&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20013">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/coronary-artery-perforation/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20013">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20013/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20013">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20013.s15">
        <title>References</title>
        <ref id="article-20013.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lemmert</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>van Bommel</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Diletti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilschut</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>de Jaegere</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Zijlstra</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Daemen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Mieghem</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2017</year>
            <month>Sep</month>
            <day>22</day>
            <volume>6</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">28939719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendry</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Eichhofer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mamas</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fath-Ordoubadi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>El-Omar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience.</article-title>
            <source>EuroIntervention</source>
            <year>2012</year>
            <month>May</month>
            <day>15</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-86</page-range>
            <pub-id pub-id-type="pmid">22580251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimony</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zahger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Van Straten</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shalev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gilutz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ilia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cafri</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention.</article-title>
            <source>Am J Cardiol</source>
            <year>2009</year>
            <month>Dec</month>
            <day>15</day>
            <volume>104</volume>
            <issue>12</issue>
            <fpage>1674</fpage>
            <page-range>1674-7</page-range>
            <pub-id pub-id-type="pmid">19962473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fasseas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Orford</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Panetta</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Denktas</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Lennon</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures.</article-title>
            <source>Am Heart J</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>147</volume>
            <issue>1</issue>
            <fpage>140</fpage>
            <page-range>140-5</page-range>
            <pub-id pub-id-type="pmid">14691432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doll</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nikolsky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lincoff</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Caixeta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLaurin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cristea</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fahy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kesanakurthy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lansky</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.</article-title>
            <source>J Interv Cardiol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>453</fpage>
            <page-range>453-9</page-range>
            <pub-id pub-id-type="pmid">19702677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dippel</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kereiakes</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Tramuta</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Shimshak</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hattemer</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Runyon</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Whang</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Abbottsmith</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>279</fpage>
            <page-range>279-86</page-range>
            <pub-id pub-id-type="pmid">11246236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimony</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mottillo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis.</article-title>
            <source>Can J Cardiol</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>843</fpage>
            <page-range>843-50</page-range>
            <pub-id pub-id-type="pmid">21862280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunning</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>Jewitt</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wainwright</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery perforation during percutaneous intervention: incidence and outcome.</article-title>
            <source>Heart</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>495</fpage>
            <page-range>495-8</page-range>
            <pub-id pub-id-type="pmid">12381642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gruberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pinnow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Flood</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tebeica</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Waksman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Satler</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Pichard</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Lindsay</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention.</article-title>
            <source>Am J Cardiol</source>
            <year>2000</year>
            <month>Sep</month>
            <day>15</day>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>680</fpage>
            <page-range>680-2, A8</page-range>
            <pub-id pub-id-type="pmid">10980224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stankovic</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Orlic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Corvaja</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Airoldi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chieffo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spanos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Montorfano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Finci</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sangiorgi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations.</article-title>
            <source>Am J Cardiol</source>
            <year>2004</year>
            <month>Jan</month>
            <day>15</day>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-6</page-range>
            <pub-id pub-id-type="pmid">14715351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Copeland</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Hopkins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2012</year>
            <month>Jul</month>
            <day>01</day>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-7</page-range>
            <pub-id pub-id-type="pmid">21953680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellis</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Ajluni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Popma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Bittl</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Eigler</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Cowley</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Safian</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Whitlow</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.</article-title>
            <source>Circulation</source>
            <year>1994</year>
            <month>Dec</month>
            <volume>90</volume>
            <issue>6</issue>
            <fpage>2725</fpage>
            <page-range>2725-30</page-range>
            <pub-id pub-id-type="pmid">7994814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fountain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Turi</surname>
                <given-names>ZG</given-names>
              </name>
            </person-group>
            <article-title>Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>705</fpage>
            <page-range>705-17</page-range>
            <pub-id pub-id-type="pmid">19695538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fejka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Safian</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Grines</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Finta</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marcovitz</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, management, and clinical outcome of cardiac tamponade complicating percutaneous coronary intervention.</article-title>
            <source>Am J Cardiol</source>
            <year>2002</year>
            <month>Dec</month>
            <day>01</day>
            <volume>90</volume>
            <issue>11</issue>
            <fpage>1183</fpage>
            <page-range>1183-6</page-range>
            <pub-id pub-id-type="pmid">12450595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stathopoulos</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Kossidas</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garratt</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Delayed perforation after percutaneous coronary intervention: rare and potentially lethal.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2014</year>
            <month>Jan</month>
            <day>01</day>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>E45</fpage>
            <page-range>E45-50</page-range>
            <pub-id pub-id-type="pmid">23832600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Von Sohsten</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kopistansky</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kussmaul</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Cardiac tamponade in the "new device" era: evaluation of 6999 consecutive percutaneous coronary interventions.</article-title>
            <source>Am Heart J</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>140</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-83</page-range>
            <pub-id pub-id-type="pmid">10925343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;bel</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Voelker</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Haase</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Karsch</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Occurrence of a saccular pseudoaneurysm formation two weeks after perforation of the left anterior descending coronary artery during balloon angioplasty in acute myocardial infarction.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>341</fpage>
            <page-range>341-6</page-range>
            <pub-id pub-id-type="pmid">10402295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hern&#x000e1;ndez-Enr&#x000ed;quez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lairez</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Campelo-Parada</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lhermusier</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bouisset</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Roncalli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elbaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carri&#x000e9;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boudou</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new-generation covered stents.</article-title>
            <source>J Interv Cardiol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>617</fpage>
            <page-range>617-623</page-range>
            <pub-id pub-id-type="pmid">29808511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20013.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Shamouelian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dahodwala</surname>
                <given-names>MQ</given-names>
              </name>
            </person-group>
            <article-title>Coronary Artery Perforation Following Percutaneous Coronary Intervention.</article-title>
            <source>J Invasive Cardiol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>122</fpage>
            <page-range>122-31</page-range>
            <pub-id pub-id-type="pmid">26945255</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
